论文部分内容阅读
我院是一所三级甲等精神卫生专科医院,年收治3000余病人,年门诊量达14万人次.然我院药费比例历来较低,仅占医疗收入20%左右(其中门诊药费占70%,住院药费占30%),但近年来,随着临床大量新药、合资药的广泛应用,使得药品本身的成本大幅度提高,同类药品新药价是老药的几十倍甚至百倍.如不采取积极有效的措施,必然导致药费增长过快,突破规定的药费增长限额.上海市自1994年7月推行医院医药费用“总量控制,结构调整”政策,经几年的实践证明,有利于医院管理工作走良性循环的道路.
Our hospital is a tertiary mental health specialist hospital. It treats more than 3,000 patients annually and has an annual outpatient visit of 140,000. However, the proportion of medical expenses in our hospital has historically been low, accounting for only about 20% of medical income (including outpatient medical expenses). 70% accounted for 30% of the cost of hospitalized drugs, but in recent years, with the extensive use of a large number of new drugs and joint ventures, the cost of the drugs themselves has increased substantially. The price of new drugs of the same type of drugs is ten times or even hundred times that of old drugs. If you do not take active and effective measures, it will inevitably lead to excessive growth of drug costs and break through the prescribed growth limit of drug costs. Since July 1994, Shanghai has implemented the policy of “total control and structural adjustment” of hospital medical expenses, after several years of Practice has proved that it is beneficial to hospital management to take a virtuous cycle.